뉴스

베이징, 2021 년 5 월 18 일-Lepu Medical Technology (Beijing) Co., Ltd. ("Lepu Medical"), 첨단 의료 기기 및 장비 개발, 제조 및 마케팅 전문 글로벌 선도 기업 5 월 14 일에 중국과 전 세계의 글로벌 COVID-19 통제 및 예방을 더욱 촉진하기 위해 이론과 모범 사례를 공유하기 위해 가상 "COVID-19 탐지 방법 세미나" 를 개최했습니다.

The seminar, which included a virtual training session and a virtual visit to Lepu Medical’s headquarters in Beijing, was part of the seven-day “Seminar on COVID-19 Methods For Detection,” sponsored by China’s Ministry of Commerce and organized by Beijing Holley-Cotect Pharmaceuticals Co., Ltd. The seminar aimed to help other countries and regions to control the pandemic by sharing China’s advanced prevention and control experience. 

라이브 스트리밍 비디오를 통해 사실상 개최 된 세미나에는 질문 및 답변 세션, 세미나 공유, 클라우드 방문 및 기타 가상 형식이 포함되었습니다. 케냐, 모리셔스, 베네수엘라, 페루, 우크라이나, 스리랑카, 이라크, 에티오피아, 이란 등 9 개국 과학연구기관의 의료인, 정부 직원, 연구자 등 총 77 명이 참가한 가운데 레푸 메디컬 주최 강연 및 클라우드 방문.

During the seminar, Lepu Medical invited Dr. Jing Yu from the Wuhan Hospital of Traditional Chinese and Western Medicine to deliver a training lecture on basic knowledge and practical experiences of SARS-COV-2 detection, antigen rapid tests, and biochemical indicators for diagnosis. The training course covered the closed loop and seamless SARS-COV-2 detection process from sampling, sample transfer, sample receipt, testing, result reporting and medical waste treatment in various settings including medical institutions, communities, mass screening sites and public places. The seminar, which was well-received by attendees, included a question and answer session in which Dr. Jing Yu and representatives from Lepu Medical answered detailed questions on COVID-19 detection methods, and provided best practice advice to attendees. 

Lepu Medical’s 2019-nCoV 항원 신속한 테스트 키트 (콜로이드 골드 면역 크로마토그래피), a simple screening method for COVID-19 that delivers quick results with high negative predictive value (NPV), was held up as an example by Dr. Yu during the training session. The antigen test method, which is non-invasive, simple to use, cost-efficient, convenient, rapid, stable and accurate has shown high sensitivity of 95.06% and high specificity of 99.62% in clinical trials in IPE Center for Clinical Laboratory, a Lepu Medical subsidiary. Results can be quickly retrieved in 15 minutes. Lepu Medical provides both Lepu Professional Antigen test kits for use by medical institutions and Lepu Antigen self-test kits for individual self-test use, to support diverse testing needs. The Lepu Antigen self-test kit is already approved by BfArM and available in Germany. 

“(For the antigen rapid test,) the positive results can be seen in the early stage after the symptoms (emerged) or in the infection,” said Dr. Yu, addressing participant questions raised about test timing and sensitivity during the lively Q&A session following her lecture, “The sensitivity of the antigen detection depends on the prevalence of the virus. The positive rate of the antigen rapid test is useful in the high prevalent area. If the viral load of the sample is high, the sensitivity of the antigen test and PCR test can be the same.  All biomarkers combined together can be the most effective.”

In addition to the 2019-nCoV 항원 신속한 테스트 키트 (콜로이드 골드 면역 크로마토그래피), Lepu Medical offers other comprehensive diagnostic solutions including nucleic acid series products and solutions, which provide standard tests for COVID-19 diagnosis, and neutralization antibody test products to detect the effectiveness of COVID-19 vaccines in the post-pandemic period. Other COVID-19 products and solutions include sample collection kits, manual sample extraction kits, automated sample extractors, nucleic acid test kits, real-time PCR systems for standard clinical nucleic acid diagnostics, and antibody test kits and systems for vaccine effect evaluation.

Lepu Medical has been providing proactive support to control the COVID-19 pandemic from an early stage. In early 2020, during the outbreak in China, Lepu Medical started emergency production of medical equipment supplies and donated more than RMB5 million of personal protective equipment (PPE), medical devices and cash to severely impacted areas. The company also developed an online free medical consulting system “Doctor Lepu” to assist patients remotely while supporting social distancing. Lepu Medical subsidiaries also dispatched volunteers and a medical aid team to the city of Wuhan and provided mass COVID-19 nucleic acid testing in Beijing where the company is headquartered. Lepu Medical’s products were also widely used across China’s hospitals, medical centers and COVID-19 testing sites. These products included Lepu Medical’s automatic PCR analysis system, personal forehead thermometers, pulse oximeters, monitors, electrocardiographs, household oxygen generators and pharmaceutical products.

20 개 이상의 글로벌 OEM 파트너가있는 80 개 이상의 국가 및 지역을 포괄하는 글로벌 기업인 Lepu Medical은 COVID-19 대응하기위한 전 세계 노력을 지원하기 위해 연구 개발, 제조 및 유통 분야에서 글로벌 네트워크와 리소스를 활용하고 있습니다. 회사의 다양한 관련 제품은 유럽에서 CE 인증서를 받았으며 미국 식품의 약국 (FDA) 의 승인을 받았으며 전염병에 맞서 싸우기 위해 140 개 이상의 국가에 배포되었습니다. Lepu Medical은 2021 년 1 월부터 전국적인 테스트를 수행하기 위해 2 천만 개 이상의 항원 테스트 키트를 제공함으로써 오스트리아의 학교 재개를 지원하면서 여러 국가에서 정사이즈 대량 테스트를 지원했습니다. 중국 수출용 화이트리스트에 등재 된 Lepu SARS-CoV-2 Antigen Rapid Test Kit는 독일의 공식 연구소 PEI의 인증을 받았으며 독일 연방 약물 및 의료 기기 연구소 (BfArM) 의자가 테스트를 위해 특별 승인을 받았습니다.

Upholding the company’s spirit of integrity, quality and scientific innovation, Lepu Medical will continue to focus on combating the COVID-19 pandemic and go above and beyond to provide the best quality of products and services to satisfy the needs of healthcare professionals and patients.